Minimally invasive valve surgery including patients of combined simultaneous surgery: a retrospective study.

Objective: This study investigated the perioperative safety and advantages of performing a minimally invasive valve surgery (MIVS) and conducting a preliminary examination of the combined simultaneous surgery (CSS).

Methods: A total of 29 patients (16 men and 13 women; mean age, 58.41 ± 13.

Minimally invasive direct coronary artery bypass after percutaneous coronary intervention.

Objectives: Minimally invasive direct coronary artery bypass (MIDCAB) with the left internal thoracic artery (LITA) provides excellent long-term results for isolated left anterior descending coronary artery (LAD) disease. We tried to evaluate the impact of the previous percutaneous coronary intervention (p-PCI) for LAD on the clinical outcomes of MIDCAB in this study.

Methods: A total of 197 patients with isolated LAD disease underwent MIDCAB in our center from February 2009 to May 2020.

A pilot study of a novel biodegradable magnesium alloy airway stent in a rabbit model.

Objective: To preliminarily investigate the feasibility of bioabsorption tracheal stenting for the therapeutic application of congenital tracheal stenosis (CTS).

Study Design: Experimental research.

Setting: Shanghai Children Medical Center, National Children's Medical Center.

One-stage surgical correction of congenital tracheal stenosis complicated with congenital heart disease in infants and young children.

Objectives: Although the outcome of surgical treatment of congenital tracheal stenosis (CTS) has improved, surgical intervention for these patients, especially for those with associated congenital heart disease (CHD) remains challenging. In this report, we summarized our experience with these defects.

Methods: Clinical data were collected for children undergoing tracheoplasty and CHD surgery from January 2001 to March 2013.

[The Expression of hTERT mRNA and p16 Protein in Non-small Cell Lung Cancer.].

Background: hTERT and p16 are involved in oncogenesis and development of tumor. The aim of this study is to investigate the expression of human telomerase reverse transcriptase (hTERT) and p16 in non-small cell lung cancer (NSCLC).

Methods: The quantitative reverse transcription-polymerase chain reaction (RT-qPCR) and immunohistochemistry were applied to detect the hTERT and p16 in tissue of 21 cases of lung benign diseases and 117 of non-small cell lung cancer and adjacent tissues, respectively.